135 related articles for article (PubMed ID: 16258523)
1. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression.
Kersting C; Kuijper A; Schmidt H; Packeisen J; Liedtke C; Tidow N; Gustmann C; Hinrichs B; Wülfing P; Tio J; Boecker W; van Diest P; Brandt B; Buerger H
Lab Invest; 2006 Jan; 86(1):54-61. PubMed ID: 16258523
[TBL] [Abstract][Full Text] [Related]
2. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.
Wang X; Jones TD; Zhang S; Eble JN; Bostwick DG; Qian J; Lopez-Beltran A; Montironi R; Harris JJ; Cheng L
Mod Pathol; 2007 Feb; 20(2):175-82. PubMed ID: 17192792
[TBL] [Abstract][Full Text] [Related]
3. Egfr amplification specific gene expression in phyllodes tumours of the breast.
Agelopoulos K; Kersting C; Korsching E; Schmidt H; Kuijper A; August C; Wülfing P; Tio J; Boecker W; van Diest PJ; Brandt B; Buerger H
Cell Oncol; 2007; 29(6):443-51. PubMed ID: 18032821
[TBL] [Abstract][Full Text] [Related]
4. Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma.
Kersting C; Tidow N; Schmidt H; Liedtke C; Neumann J; Boecker W; van Diest PJ; Brandt B; Buerger H
Lab Invest; 2004 May; 84(5):582-7. PubMed ID: 15031710
[TBL] [Abstract][Full Text] [Related]
5. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.
Tse GM; Lui PC; Vong JS; Lau KM; Putti TC; Karim R; Scolyer RA; Lee CS; Yu AM; Ng DC; Tse AK; Tan PH
Breast Cancer Res Treat; 2009 Apr; 114(3):441-8. PubMed ID: 18443904
[TBL] [Abstract][Full Text] [Related]
6. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
[TBL] [Abstract][Full Text] [Related]
7. Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.
Cani AK; Hovelson DH; McDaniel AS; Sadis S; Haller MJ; Yadati V; Amin AM; Bratley J; Bandla S; Williams PD; Rhodes K; Liu CJ; Quist MJ; Rhodes DR; Grasso CS; Kleer CG; Tomlins SA
Mol Cancer Res; 2015 Apr; 13(4):613-9. PubMed ID: 25593300
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
[TBL] [Abstract][Full Text] [Related]
9. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.
Gatalica Z; Vranic S; Ghazalpour A; Xiu J; Ocal IT; McGill J; Bender RP; Discianno E; Schlum A; Sanati S; Palazzo J; Reddy S; Pockaj B
Oncotarget; 2016 Jan; 7(2):1707-16. PubMed ID: 26625196
[TBL] [Abstract][Full Text] [Related]
10. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
11. Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features.
Suo Z; Nesland JM
Ultrastruct Pathol; 2000; 24(6):371-81. PubMed ID: 11206334
[TBL] [Abstract][Full Text] [Related]
12. Phyllodes tumors of the breast segregate in two groups according to genetic criteria.
Laé M; Vincent-Salomon A; Savignoni A; Huon I; Fréneaux P; Sigal-Zafrani B; Aurias A; Sastre-Garau X; Couturier J
Mod Pathol; 2007 Apr; 20(4):435-44. PubMed ID: 17334353
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
[TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
15. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.
Ang MK; Ooi AS; Thike AA; Tan P; Zhang Z; Dykema K; Furge K; Teh BT; Tan PH
Breast Cancer Res Treat; 2011 Sep; 129(2):319-29. PubMed ID: 20945089
[TBL] [Abstract][Full Text] [Related]
16. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.
Bhargava R; Gerald WL; Li AR; Pan Q; Lal P; Ladanyi M; Chen B
Mod Pathol; 2005 Aug; 18(8):1027-33. PubMed ID: 15920544
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and molecular markers in breast phyllodes tumors.
Korcheva VB; Levine J; Beadling C; Warrick A; Countryman G; Olson NR; Heinrich MC; Corless CL; Troxell ML
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):119-25. PubMed ID: 21030860
[TBL] [Abstract][Full Text] [Related]
18. Whole-genome profiling helps to classify phyllodes tumours of the breast.
Laé M; La Rosa P; Mandel J; Reyal F; Hupé P; Terrier P; Couturier J
J Clin Pathol; 2016 Dec; 69(12):1081-1087. PubMed ID: 27207013
[TBL] [Abstract][Full Text] [Related]
19. Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups.
Tan WJ; Lai JC; Thike AA; Lim JC; Tan SY; Koh VC; Lim TH; Bay BH; Tan MH; Tan PH
Breast Cancer Res Treat; 2014 Jun; 145(3):635-45. PubMed ID: 24831776
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of gene amplifications and coamplifications in breast cancer.
Al-Kuraya K; Schraml P; Torhorst J; Tapia C; Zaharieva B; Novotny H; Spichtin H; Maurer R; Mirlacher M; Köchli O; Zuber M; Dieterich H; Mross F; Wilber K; Simon R; Sauter G
Cancer Res; 2004 Dec; 64(23):8534-40. PubMed ID: 15574759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
